[frame style = ”modern” image_path = ”https://www.lvad.nl/wp-content/uploads/Ad-Buijing.png” link_to_page = ”http://www.youtube.com/watch?v=_mdDvGzmH_8 ″ Target = ”_ blank” description = ”” size = ”three_col_small”] On October 5, 2010, Ad Buijing can be seen in the Gold Mine program of the KRO. In it, he tells his story about the life he has with the LVAD. Shortly after the recordings of this program, Ad will be transplanted.

[frame style = ”modern” image_path = ”https://www.lvad.nl/wp-content/uploads/article-1268923-094F6237000005DC-780_634x436.jpg” link_to_page = ”http://www.dailymail.co.uk /health/article-1268923/British-boy-13-youngest-patient-receive-life-saving-heart-pump-soon-replace-transplants.html ”target =” _ blank ”description =” ”size =” four_col_large ”]

In April 2010, it is announced that an LVAD from Heartware was implanted at Andrew Ames on Boxing Day 2009. This made him the youngest ever receiver of an LVAD. In July 2010, Andrew has a heart transplant  undergo.

[frame style = ”modern” image_path = ”https://www.lvad.nl/wp-content/uploads/Heartmate-II-röntgenfoto.png” link_to_page = ”http://medgadget.com/2010/01/heartmate_ii_lvad_as_permanent_option_for_heart_failure .html ”target =” _ blank ”description =” ”size =” four_col_large ”] January 2010 The FDA approves the implantation of Thoratec's HeartMate II LVAD as a destination therapy. This gives the green light from America for LVAD as a treatment for heart failure.